ENDPOINTS

23andMe files for bankruptcy, CEO Wojcicki steps down

Rounding off a turbulent few years, genetic testing company 23andMe is filing for bankruptcy. CEO Anne Wojcicki has resigned after three failed attempts at taking the company private. The biotech initiated Chapter 11 proceedings in ...

Mar 24, 2025 - 11:45
 0
23andMe files for bankruptcy, CEO Wojcicki steps down
Rounding off a turbulent few years, genetic testing company 23andMe is filing for bankruptcy. CEO Anne Wojcicki has resigned after three failed attempts at taking the company private. The biotech initiated Chapter 11 proceedings in ...
Read More

Tags:

Previous Article

This trailblazer shows how sustainability reporting should shape corporate strategy

Next Article

Weather tracker: Severe thunderstorms threaten flooding in northern Australia

Related Posts

What FDA, NIH hearings say about Trump drug, health policy

What FDA, NIH hearings say about Trump drug, health policy

Mar 7, 2025  0

Jazz to buy Chimerix for $935M to get brain tumor drug five months ahead of PDUFA

Jazz to buy Chimerix for $935M to get brain tumor drug ...

Mar 5, 2025  0

AstraZeneca reports Phase 3 win for hypoparathyroidism drug eneboparatide

AstraZeneca reports Phase 3 win for hypoparathyroidism ...

Mar 17, 2025  0